Condition
Locally Advanced Gastric Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Locally Advanced Gastric Cancer clinical trials that are recruiting, at sites in 3 countries (most in China (4), Italy (1), South Korea (1)). By phase: Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3Countries
Newest Locally Advanced Gastric Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| HIPEC-primed therapy with serplulimab plus SOX/XELOX for locally advanced gastric cancer | Phase 2 | Shanghai | Recruiting | Jun 2, 2026 |
| Personalized ultrafractionated radiation plus immunotherapy for unresectable stomach cancer | — | Seoul, Select Province/State | Recruiting | May 26, 2026 |
| AI-based prediction of who will respond to pre-surgery immunotherapy in locally advanced gastric cancer | — | Fuyang, Anhui and 8 other locations | Recruiting | Feb 10, 2026 |
| Robotic surgery for advanced gastric cancer | — | Changchun, Jilin | Recruiting | Mar 18, 2025 |
| Comparing two surgical methods for advanced gastric cancer after chemotherapy | — | Wuhan, Hubei | Recruiting | Sep 19, 2024 |
| Comparing two types of lymphadenectomy after chemotherapy for stomach cancer | Phase 3 | Siena | Recruiting | May 23, 2019 |
All recruiting trials (6)
-
HIPEC-primed therapy with serplulimab plus SOX/XELOX for locally advanced gastric cancer
This study tests a HIPEC-priming approach followed by PD-1 blocker–based chemotherapy to see if it helps people with locally advanced gastric cancer who have not yet spread.
-
Personalized ultrafractionated radiation plus immunotherapy for unresectable stomach cancer
This study tests, in patients with unresectable locally advanced stomach cancer who have not progressed after initial therapy, whether adding PULSAR radiation to ongoing systemic treatment improves control of the tumor.
-
AI-based prediction of who will respond to pre-surgery immunotherapy in locally advanced gastric cancer
A real-world study will test whether an AI system can predict which patients with locally advanced gastric cancer will respond to neoadjuvant chemotherapy plus PD-1 inhibitors before surgery.
-
Robotic surgery for advanced gastric cancer
This study is testing if robotic surgery can safely help people with advanced stomach cancer by reducing blood loss and hospital stays compared to traditional methods.
-
Comparing two surgical methods for advanced gastric cancer after chemotherapy
This study is testing whether a less extensive stomach surgery can help people with advanced gastric cancer live longer and feel better after chemotherapy compared to a more complete surgery.
-
Comparing two types of lymphadenectomy after chemotherapy for stomach cancer
This study is testing whether a more extensive type of surgery for stomach cancer after chemotherapy can help patients do better than the standard surgery.
Related topics
Quick answers
How many Locally Advanced Gastric Cancer clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (4 trials), Italy (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.